The Other Side of SSVI: What Hospice Leaders Should Watch Beyond Non-Hospice Spending

Much of the industry discussion around CMS’s new Service and Spending Variation Index, or SSVI, has focused on non-hospice spending. But the utilization side deserves just as much attention. CMS is also looking at patterns such as long lengths of stay, high live-discharge rates, and beneficiaries returning to the same hospice shortly after discharge. Those patterns do not prove that a hospice made the wrong decision, but they can become flags that lead CMS to look more closely at the eligibility, recertification, and discharge decisions underneath the claims.

With the FY 2027 Hospice Final Rule taking effect October 1, hospice leaders should understand those decisions now, not after CMS asks for the records behind them.

SSVI Gives CMS Another Way to Decide Where to Look

SSVI combines eight hospice utilization measures with non-hospice Medicare spending into a claims-based score.

What matters most is how CMS plans to use it.

CMS says SSVI can help identify hospices with unusual patterns across multiple measures and will be one of several sources of information used in program integrity efforts. Those efforts can include targeted education, medical review, and investigations.

CMS also makes clear that being an outlier on one measure does not necessarily indicate poor performance or inappropriate practices. Legitimate clinical and operational circumstances can create variation.

Hospice News has described SSVI as part of a broader “matrix” CMS can use for program integrity and specifically points to live-discharge and visit patterns as areas providers should watch.

The practical implication for hospice leaders is clear: understand the patterns CMS can see and the decisions behind them.

Non-Hospice Spending Is Only Half the Story

Non-hospice spending is getting attention for good reason. It represents up to half of the potential SSVI points, and CMS has been explicit about its concern over Medicare spending outside the hospice benefit.

CHAP has focused heavily on relatedness and the need for defensible clinical decisions around services determined to be outside the hospice benefit. CHAP also recommends that hospices should understand what their SSVI data suggests and be prepared to explain the clinical and operational decisions behind it.

The utilization measures bring into focus the clinical and operational decisions behind the claims.

The Utilization Measures, To Which Hospice Leaders Should Pay Attention

Three measures deserve particular attention:

• Long length of stay. CMS looks at the percentage of beneficiaries discharged after a lifetime hospice stay of 180 days or more.
• Live discharges. CMS evaluates the percentage of total discharges that occur while the patient is still living.
• Rapid return after discharge. CMS also looks at how often beneficiaries return to the same hospice within seven days of a live discharge.

CMS explains why these patterns matter. In the Final Rule, the agency says long lengths of stay combined with high live-discharge rates may signal inappropriate enrollment of ineligible beneficiaries. CMS also notes that a brief discharge followed by quick readmission may raise questions about why the discharge occurred.

These patterns can have legitimate clinical explanations. Claims data, however, cannot explain why an individual eligibility, recertification, or discharge decision was appropriate. The clinical record must do that.

The Questions Behind the Claims Data

The important question is whether the clinical decisions behind the utilization pattern are well supported.

• For long lengths of stay, can the record clearly support continued eligibility over time?
• For repeated recertifications, does the documentation show the longitudinal evidence of decline behind each decision?
• For live discharges or rapid returns, is the clinical rationale clear enough to stand up in a medical review?

These questions get to the core issue: whether the clinical record supports the judgment that was made. CMS can identify a claims pattern without knowing the full clinical story. If that pattern leads to closer review, the record needs to support the decision.

By the Time SSVI Finds the Pattern, the Decisions Have Already Been Made

SSVI is built on finalized claims data, so it is retrospective by design.

By the time an unusual pattern appears, the patient may have gone through several recertification periods, or a discharge has already occurred. As census, clinicians, and locations grow, variation in those decisions also becomes harder for leaders to see.

Finding the pattern after the fact gives a hospice an opportunity to investigate it. But by then, the decisions behind it are already part of the record.

The better position is to identify weak support while the decision is still being made.

That means bringing together the patient’s longitudinal history, identifying gaps in clinical support early, applying a consistent approach to high-stakes decisions, and addressing weaknesses while there is still time to act.

What Hospice Leaders Should Do Now

With the FY 2027 Final Rule taking effect October 1, leadership teams should review their published FY 2024 and FY 2025 SSVI data now.

1. Look beyond the total score. Identify which measures are generating points. Compare patterns year over year. Pay particular attention to length of stay, live discharges, and rapid returns.
2. Then move from the claims data into the clinical record. Review representative long-stay cases. Look at whether recertification documentation consistently supports continued eligibility and reflects the patient’s trajectory over time. Examine live discharges and rapid returns. Determine whether certain patterns are concentrated within branches, teams, or clinicians.
3. Most importantly, ask: If CMS followed this claims pattern into our records, would we be confident in the decisions it finds?

CMS has made SSVI data and related materials available here.

Support the Decision Before It Becomes a Signal

Akssi helps hospice organizations strengthen those decisions earlier.

Recert Assist brings together the longitudinal patient story, highlights evidence of decline, and helps clinical teams more consistently support high-stakes recertification decisions before weak decision support becomes larger exposure.

Audit Scan proactively identifies documentation and compliance gaps while they are still actionable and helps teams focus on issues that could create greater organizational risk.

Akssi sits on top of the hospice EMR to help strengthen the decisions behind the utilization patterns CMS is watching.

As CMS adds another way to identify where closer scrutiny may be warranted, hospice leaders should not wait for claims data to tell them where vulnerabilities exist.

The stronger position is to find and address them first.

Explore how Akssi can help hospice teams strengthen the decisions behind the metrics CMS is watching.